Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population.

Pharmacological research - 1 Feb 2006

Scordo Maria Gabriella, Dahl Marja-Liisa, Spina Edoardo, Cordici Francesco, Arena Maria Grazia

Abstract excerpt

Allelic variation at the CYP2D6 gene has been suggested to be associated with CNS disorders, including Parkinson's disease and Lewy body dementia. In order to elucidate whether a relationship exists between CYP2D6 polymorphism and the risk of developing Alzheimer's disease (AD), CYP2D6 allele and genotype frequencies have been evaluated in 94 patients from Southern Italy (29 men and 65 women, aged 74+/-8 years)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Alleles
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2D6

Share to Gene Frequency

Share to Pharmacogenetics

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 16337409
DOI: 10.1016/j.phrs.2005.10.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population.PMID 16337409Read ↗

CYP2D6 gene polymorphism as a probable risk factor for Alzheimer's disease and Parkinson's disease with dementia.Semantic proximity Read ↗

CYP2D6 polymorphisms in Alzheimer's disease, with and without extrapyramidal signs, showing no apolipoprotein E epsilon 4 effect modification.Semantic proximity Read ↗

No evidence of an association between CYP2D6 polymorphisms among Japanese and dementia with Lewy bodies.Semantic proximity Read ↗

No association between familial Alzheimer disease and cytochrome P450 polymorphisms.Semantic proximity Read ↗

Frequency of CYP2D6 allelic variants in multiple sclerosis.Semantic proximity Read ↗

Quantitative assessment of CYP2D6 polymorphisms and risk of Alzheimer's disease: a meta-analysis.Semantic proximity Read ↗

The CYP2D6B allele is not overrepresented in a population of German patients with idiopathic Parkinson's disease.Semantic proximity Read ↗

CYP2D6 polymorphism in Parkinson's disease: the Rotterdam Study.Semantic proximity Read ↗

Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's disease.Semantic proximity Read ↗

Genetic polymorphism of cytochrome P450 2D6 in idiopathic Parkinson disease and diffuse Lewy body disease.Semantic proximity Read ↗

CYP2D6*4 polymorphism is not associated with Parkinson's disease and has no protective role against Alzheimer's disease in the Korean population.Semantic proximity Read ↗

Pharmacogenetic Aspects of Therapy with Cholinesterase Inhibitors: The Role of CYP2D6 in Alzheimers Disease PharmacogeneticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.